All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Peptides and other treatments for tennis elbow

Dr. David Geier

11K views on YouTubeWatch on YouTube

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptides for JointsMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Peptides and other treatments for tennis elbow, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

Peptides and other treatments for tennis elbow should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Peptides and other treatments for tennis elbow" from Dr. David Geier. We read the clip as a Peptides for Joints claim about Peptides for Joints, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Tennis elbow often progresses from acute tendinitis to chronic tendinosis where anti-inflammatory treatments like cortisone may actually worsen long-term outcomes

The reason this review is not generic is the source wording and the canonical claim label "peptide joint peptides and other treatments for tennis elbow." In this clip, the useful excerpt is: "Tennis elbow often progresses from acute tendinitis to chronic tendinosis where anti-inflammatory treatments like cortisone may actually worsen long-term outcomes" That wording changes the review because it points to Peptides for Joints evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Multifunctionality and Possible Medical Application of the BPC 157 Peptide (2025), Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing (2019), and Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (2025), plus the creator's own wording. Peptides for Joints decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Eccentric strengthening exercises like the Tyler Twist are the evidence-based foundation and should be tried for at least six to eight weeks first
People who land here are usually comparing the Peptides for Joints claim with peptide and joint.
The strongest next step is to compare the claim with FormBlends' Peptides for Joints guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Tennis elbow often progresses from acute tendinitis to chronic tendinosis where anti-inflammatory treatments like cortisone may actually worsen long-term outcomes

FormBlends verdict

Peptides for Joints evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The video is useful as a prompt for better questions, but it should not be treated as a personalized treatment plan.
  • Tennis elbow often progresses from acute tendinitis to chronic tendinosis where anti-inflammatory treatments like cortisone may actually worsen long-term outcomes
  • Eccentric strengthening exercises like the Tyler Twist are the evidence-based foundation and should be tried for at least six to eight weeks first

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Tennis elbow often progresses from acute tendinitis to chronic tendinosis where anti-inflammatory treatments like cortisone may actually worsen long-term outcomes
  • Eccentric strengthening exercises like the Tyler Twist are the evidence-based foundation and should be tried for at least six to eight weeks first
  • PRP injections have randomized trial evidence showing superior long-term results compared to cortisone for tennis elbow
  • BPC-157 addresses the poor blood supply issue in tendons through angiogenesis with strong animal data supporting faster tendon healing
  • Local injection near the lateral epicondyle is preferred over oral BPC-157 for this focal tendon condition

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

Tennis Elbow Treatment: Where Peptides Fit in the Recovery Toolkit

Dr. David Geier, a sports medicine specialist, provides a thorough look at treatment options for lateral epicondylitis, commonly known as tennis elbow. Despite its name, this condition affects far more than tennis players. Anyone who performs repetitive gripping, twisting, or lifting motions with their hands and forearms can develop it. Carpenters, plumbers, office workers who use a mouse all day, and weight lifters are all commonly affected. The condition involves degeneration and microtearing of the tendons that attach to the outer elbow, and it can be maddeningly persistent once it sets in.

What makes tennis elbow so frustrating is that it often does not respond to the usual playbook of rest, ice, and anti-inflammatory medications. Many patients go through months or even years of on-and-off symptoms, getting better for a while and then flaring up again with any return to the activities that caused it. This persistence has driven significant interest in regenerative treatments, including peptides, that can address the underlying tendon degeneration rather than just managing symptoms.

Why Tennis Elbow Is So Stubborn

The tendons affected in tennis elbow (primarily the extensor carpi radialis brevis) have poor blood supply, which is a recurring theme in tendon injuries throughout the body. Blood brings the growth factors, oxygen, and nutrients needed for tissue repair. When blood supply is limited, repair happens slowly and incompletely.

The condition starts as tendinitis (acute inflammation of the tendon) but often progresses to tendinosis (chronic degeneration without significant inflammation). This distinction matters for treatment because anti-inflammatory approaches like cortisone injections and NSAIDs target inflammation, which may not be the primary driver in chronic cases. If the tendon is degenerating rather than inflaming, anti-inflammatory treatment addresses the wrong process.

Cortisone injections for tennis elbow illustrate this perfectly. They provide excellent short-term pain relief, often within days, because they powerfully suppress inflammation. But multiple studies have shown that cortisone-treated tennis elbow has worse long-term outcomes than untreated tennis elbow. The steroid appears to temporarily mask symptoms while potentially impairing the healing process, leading to more recurrence and slower ultimate recovery.

Conservative Treatment Foundation

Before discussing advanced treatments, Dr. Geier emphasizes that the foundation of tennis elbow management starts with activity modification and eccentric strengthening exercises. Eccentric exercises involve slowly lowering a weight with the wrist, which loads the tendon in a controlled way that stimulates repair and remodeling. The Tyler Twist exercise using a FlexBar is one of the most studied and effective eccentric protocols for tennis elbow.

Counterforce bracing (the strap that wraps around the forearm just below the elbow) can reduce the load on the affected tendon during activities and provide symptom relief. It does not fix the underlying problem, but it buys time and reduces pain while the tendon heals. Wrist splinting at night can also help by preventing the wrist from flexing into positions that stretch the already irritated tendon.

Physical therapy that includes eccentric strengthening, manual therapy, and progressive loading protocols is effective for the majority of tennis elbow cases when given enough time. The challenge is that time means months, not weeks, and many patients get discouraged and look for faster solutions.

Regenerative Treatments: PRP and Peptides

For patients who have failed conservative treatment after three to six months, regenerative options become relevant. PRP (platelet-rich plasma) injections for tennis elbow have a growing evidence base. Several randomized controlled trials have shown that PRP provides superior long-term outcomes compared to cortisone injections, with better pain relief and functional improvement at six and twelve months post-treatment.

The mechanism makes sense: PRP delivers concentrated growth factors directly to the degenerating tendon, stimulating the repair process that the tendon cannot mount effectively on its own due to its poor blood supply. It is essentially bringing the healing resources to a tissue that is too far from the bloodstream to access them naturally.

BPC-157 enters the picture as a peptide that can complement or potentially substitute for PRP in some cases. Its pro-angiogenic effects (promoting new blood vessel formation) directly address one of the fundamental problems with tendon healing: inadequate blood supply. By stimulating VEGF and promoting angiogenesis in and around the degenerating tendon, BPC-157 may help establish the vascular infrastructure needed for sustained repair.

Animal studies on BPC-157 for tendon healing are consistently positive. Rats treated with BPC-157 after tendon transection showed faster healing, stronger tendon-to-bone attachment, and better functional recovery compared to untreated controls. The peptide has also shown protective effects against tendon damage when administered before an injury, suggesting it could serve both therapeutic and preventive roles.

How Practitioners Are Using Peptides for Tennis Elbow

In clinical practice, BPC-157 for tennis elbow is typically administered via subcutaneous injection near the lateral epicondyle (the bony bump on the outside of the elbow where the tendons attach). Some practitioners inject directly into the tendon sheath, similar to how PRP is administered, while others use subcutaneous injection near the area and rely on the peptide's systemic distribution.

Dosing protocols commonly involve 250-500 micrograms of BPC-157 injected daily or every other day for four to eight weeks. Some practitioners combine BPC-157 with TB-500 (thymosin beta-4), which has complementary tissue repair properties. TB-500 promotes cell migration to the injury site and has anti-inflammatory effects that can support the healing environment while BPC-157 drives angiogenesis and growth factor expression.

Oral BPC-157 is another option, though its effectiveness for a localized tendon condition is debated. The oral route is certainly more convenient, but the question of whether enough peptide reaches the target tissue at therapeutic concentrations is not definitively answered. For focal tendon problems, local injection is generally preferred by practitioners who use BPC-157 regularly.

Making a Treatment Decision

The treatment ladder for tennis elbow generally follows this sequence: start with activity modification and eccentric exercises for at least six to eight weeks. Add bracing and physical therapy if needed. If symptoms persist beyond three to six months of consistent conservative treatment, consider regenerative options.

PRP is the regenerative option with the strongest evidence base and broadest acceptance. It requires an office visit but is a single procedure (or sometimes two to three sessions) that provides a focused healing stimulus. BPC-157 is a more accessible option that can be used at home over a longer treatment course and may be combined with PRP for enhanced results.

Surgery for tennis elbow is rarely needed and is reserved for patients who have failed all conservative and regenerative treatments after at least six to twelve months. The surgical procedure involves removing the damaged portion of the tendon and reattaching healthy tissue to the bone. Success rates are generally good, but recovery takes several months and the risks of any surgical procedure apply.

The most important message from this discussion is that patience and consistency with treatment matter more than which specific intervention you choose. Tennis elbow heals slowly because tendons heal slowly. Any treatment, whether it is eccentric exercises, PRP, BPC-157, or a combination, needs time to work. Expecting resolution in days or weeks is unrealistic, and jumping from treatment to treatment without giving each one adequate time is a common mistake that prolongs the recovery process.

Prevention and Long-Term Management

For people who have recovered from tennis elbow and want to prevent recurrence, several strategies reduce the risk of the condition returning. Grip strengthening exercises maintained as part of a regular routine keep the forearm tendons conditioned and more resistant to overuse injury. Ergonomic modifications at the workstation, including proper mouse positioning, keyboard height, and chair adjustment, reduce the repetitive strain that triggers the condition in office workers.

For athletes, warming up the forearms before activity, using proper technique (especially in racquet sports where poor backhand mechanics are a classic cause), and gradually increasing training intensity rather than making sudden jumps in volume or load all reduce the risk of tendinopathy development. Equipment matters too. Using a racquet with the right grip size, string tension, and weight distribution can significantly reduce the force transmitted to the forearm tendons during play.

If symptoms begin to return, early intervention is far more effective than waiting for the condition to fully establish itself. Catching tennis elbow in the tendinitis phase (acute inflammation) and addressing it with rest, ice, and eccentric exercises can prevent progression to the tendinosis phase (chronic degeneration) where recovery becomes much longer and more difficult. A short preventive course of BPC-157 at the first sign of recurrent symptoms may help nip the problem before it develops into a chronic issue, though this application is based on clinical rationale rather than specific trial data.

The overall message is clear: tennis elbow is a treatable and often preventable condition that responds to a logical sequence of interventions. Starting with conservative measures, progressing to regenerative options when needed, and maintaining preventive habits after recovery creates the best long-term outcome for this common but stubborn tendon problem.

For anyone currently dealing with tennis elbow, the most important action is to start the eccentric exercise program today and commit to it for at least six to eight weeks before evaluating whether additional interventions are needed. This single step, which costs nothing and requires only a few minutes per day, is the foundation that everything else builds upon and the intervention most likely to resolve the condition without any additional treatment at all.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Dr. David Geier ·

11K views on this video

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about tennis elbow often progresses from acute tendinitis to chronic tendinosis?

Tennis elbow often progresses from acute tendinitis to chronic tendinosis where anti-inflammatory treatments like cortisone may actually worsen long-term outcomes

What does the video say about eccentric strengthening exercises like the tyler twist?

Eccentric strengthening exercises like the Tyler Twist are the evidence-based foundation and should be tried for at least six to eight weeks first

What does the video say about prp injections have randomized trial evidence showing superior long-term results?

PRP injections have randomized trial evidence showing superior long-term results compared to cortisone for tennis elbow

What does the video say about bpc-157 addresses the poor blood supply?

BPC-157 addresses the poor blood supply issue in tendons through angiogenesis with strong animal data supporting faster tendon healing

What does the video say about local injection near the lateral epicondyle?

Local injection near the lateral epicondyle is preferred over oral BPC-157 for this focal tendon condition

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Dr. David Geier, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.